Abstract:
The paper analyzes modern views on the etiology, epidemiology, pathogenesis,
methods of treating patients with chronic viral hepatitis C with concomitant non-alcoholic
fatty liver disease (NAFLD), discusses the possibility of using "dry" carbon dioxide baths
(DCDB) in this category of patients. Our research was conducted to study the effectiveness of
the integrated use of antiviral therapy (AVT) and DCDB procedures in patients with chronic
hepatitis C with concomitant NAFLD. The authors of the study were the first to suggest using
of DCDB in this category of patients. Based on the results obtained, for the first time, ideas
about the specificity of the DCDBʹs effect on the clinical course of the underlying and
concomitant diseases, on the functional state of the liver, the dynamics of lipid metabolism,
and ultrasonographic parameters of the liver were detailed. It is concluded that DCDB can be
successfully used in the complex treatment of patients with chronic hepatitis C with
concomitant NAFLD.
